Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2016

A comparison between endoscopic ultrasound-guided
rendezvous and percutaneous biliary drainage after failed ERCP
for malignant distal biliary obstruction
Jason G. Bill
Washington University School of Medicine in St. Louis

Michael Darcy
Washington University School of Medicine in St. Louis

Larissa L. Fuijii-Lau
Washington University School of Medicine in St. Louis

Daniel K. Mullady
Washington University School of Medicine in St. Louis

Srinivas Gaddam
Washington University School of Medicine in St. Louis

See next page for additional authors
Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs

Recommended Citation
Bill, Jason G.; Darcy, Michael; Fuijii-Lau, Larissa L.; Mullady, Daniel K.; Gaddam, Srinivas; Murad, Faris M.;
Early, Dayna S.; Edmundowicz, Steven A.; and Kushnir, Vladimir M., ,"A comparison between endoscopic
ultrasound-guided rendezvous and percutaneous biliary drainage after failed ERCP for malignant distal
biliary obstruction." Endoscopy International Open. 4,9. E980-E985. (2016).
https://digitalcommons.wustl.edu/open_access_pubs/5346

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

Authors
Jason G. Bill, Michael Darcy, Larissa L. Fuijii-Lau, Daniel K. Mullady, Srinivas Gaddam, Faris M. Murad,
Dayna S. Early, Steven A. Edmundowicz, and Vladimir M. Kushnir

This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/
open_access_pubs/5346

THIEME

E980

Original article

A comparison between endoscopic ultrasound-guided
rendezvous and percutaneous biliary drainage after
failed ERCP for malignant distal biliary obstruction

Authors

Jason G. Bill1, Michael Darcy2, Larissa L. Fujii-Lau1, Daniel K. Mullady1, Srinivas Gaddam1, Faris M. Murad1, Dayna S.
Early1, Steven A. Edmundowicz1, Vladimir M. Kushnir1

Institutions

1
2

submitted
13. February 2016
accepted after revision
5. July 2016

Bibliography
DOI http://dx.doi.org/
10.1055/s-0042-112584
Published online: 31.8.2016
Endoscopy International Open
2016; 04: E980–E985
© Georg Thieme Verlag KG
Stuttgart · New York
E-ISSN 2196-9736
Corresponding author
Jason G. Bill, MD
Division of Gastroenterology
Washington University School of
Medicine
660 South Euclid Ave
Campus Box 8124
St Louis, Missouri 63110
Phone: +1-314-454-8977
Fax: +1-314-747-1080
jbill@dom.wustl.edu

Division of Gastroenterology, Washington University School of Medicine in St Louis, Missouri, United States
Division of Interventional Radiology, Washington University School of Medicine in St Louis, Missouri, United States

Background and study Aims: Selective biliary cannulation is unsuccessful in 5 % to 10 % of patients
undergoing endoscopic retrograde cholangiopancreatography (ERCP) for malignant distal biliary
obstruction (MDBO). Percutaneous biliary drainage (PBD) has been the gold standard, but endoscopic ultrasound guided rendezvous (EUSr)
have been increasingly used for biliary decompression in this patient population. Our aim was
to compare the initial success rate, long-term efficacy, and safety of PBD and EUSr in relieving
MDBO after failed ERC
Patients and methods: A retrospective study involving 50 consecutive patients who had an initial
failed ERCP for MDBO. Twenty-five patients undergoing EUSr between 2008 – 2014 were compared to 25 patients who underwent PBD immediately prior to the introduction of EUSr at our
center (2002 – 2008). Comparisons were made
between the two groups with regard to technical
success, duration of hospital stay and adverse

event rates after biliary decompression.
Results: The mean age at presentation was 66.5
(± 12.6 years), 28 patients (54.9 %) were female.
The etiology of MDBO was pancreaticobiliary
malignancy in 44 (88 %) and metastatic disease
in 6 (12 %) cases. Biliary drainage was technically
successful by EUSr in 19 (76 %) cases and by PBD
in 25 (100 %) (P = 0.002). Median length of hospital stay after initial drainage was 1 day in the
EUSr group vs 5 days in PBD group (P = 0.02). Repeat biliary intervention was required for 4 patients in the EUSr group and 15 in the PBD group
(P = 0.001).
Conclusions: Initial technical success with EUSr
was significantly lower than with PBD, however
when EUSr was successful, patients had a significantly shorter post-procedure hospital stay and
required fewer follow-up biliary interventions.

Introduction

tential treatment interruptions and lower quality
of life [5]. Over the past decade, advances in technology and development of new techniques have
allowed endoscopic ultrasound guided biliary
drainage (EUS-BD) to be used as an alternative in
patients with MDBO.
Various techniques of EUS-BD have been described, including EUS-guided choledochoduodenostomy, EUS-guided rendezvous (EUSr), and
EUS-guided antegrade stent placement. Early
data have demonstrated that in expert hands,
EUS-BD is superior to PBD in regards to success
of internal biliary drainage and complications
and may overall improve a patient’s quality of
life [4]. The overall technical and clinical success
rates of EUS-BD is approximately 80 % with a complication rate of approximately 10 % [6]. Only a
few studies have attempted to compare the safety
and efficacy of EUS-BD to PBD. In the most recent
report, Khashab et al. found that EUS-BD was a

!

License terms

Malignant distal biliary obstruction (MDBO) is a
frequent complication of pancreaticobiliary and
metastatic malignancy. Endoscopic retrograde
cholangiopancreatography (ERCP) is the current
gold standard for decompressing the biliary tree
in this population [1 – 4]. However, ERCP can be
unsuccessful in 5 % to 10 % of patients with MDBO
due to tumor-related alterations in the periampullary anatomy, as well as physician and patient
factors [1]. Traditionally, unsuccessful ERCP has
been followed by percutaneous biliary drainage
(PBD) or surgical intervention to obtain biliary
decompression [1]. PBD is a well-established and
effective method for biliary decompression in the
setting of malignant obstruction. However, in
most cases, at least temporary external drainage
and repeated interventions for drain maintenance
are often required following PBD; leading to po-
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safer and potentially more efficacious alternative to PBD [2].
However, in this study a variety of EUS-BD methods were employed and PBD was only performed after a failed attempt at
EUS-BD.
Because EUS-BD techniques and their role in treating MDBO are
still evolving, it remains unclear how outcomes compare to the
current gold standard in this setting, PBD. The aim of this study
was to compare the initial success rate, long- term efficacy and
safety of PBD and EUSr in relieving MDBO after failed initial ERC

Patients and Methods
!

This was a retrospective comparative study involving 50 consecutive patients with MDBO in whom biliary decompression could
not be achieved via ERCP at a single academic tertiary referral
center. Patients were identified from a manual search of the institutional endoscopic database (Provation MD, Minneapolis, MN).
A manual chart review was performed and the clinical and endoscopic data were extracted from each patient’s electronic medical
record including demographics (age, gender), type of malignancy
(pancreaticobiliary, metastatic), laboratory data, complications,
number of repeat biliary interventions, and length of hospitalization. Twenty-five consecutive patients who underwent EUSr between 2008 and 2014 were compared to a cohort of 25 patients
who underwent PBD immediately prior to the introduction of
EUSr at our center (2002 – 2008). All EUSr procedures performed
at our institution between 2008 and 2014 were included in this
study. Patients with surgically altered anatomy (Roux-En-Y gastric bypass, pancreaticoduodenectomy, hepaticojejunostomy)
were excluded from the study. The Institutional Review Board of
Washington University School of Medicine/Barnes Jewish Hospital approved review of clinical data for the purpose of this study.
EUSr was performed at the university hospital endoscopy unit by
1 of 5 experienced endoscopists expert in EUS, ERCP, and interventional EUS. All patients were under monitored anesthesia
care and received antibiotics during the procedure and for 3 to 5
days thereafter. The number of failed ERCP attempts prior to attempting EUSr or PBD was recorded. The definition of failed biliary cannulation with ERCP was not standardized in this study
and the decision to use an alternative method of biliary cannulation was determined by the attending endoscopist.
During the time of the study, our group’s approach to EUS-BD
was to attempt EUSr rather than other techniques after failed
ERC All EUSr were performed using a trans-duodenal approach
with the echoendoscope seated in the duodenal bulb. Primarily
this decision is based on the risk of complications, primarily bile
leak, with other EUS-BD methods. After failed ERCP at our center,
EUSr was attempted during the same endoscopy session. If EUSr
was unsuccessful, the decision to use an alternative method of
EUS-BD, refer a patient to PBD, or perform ERCP at a later date
was at the discretion of the attending endoscopist. All EUSr procedures were performed using a therapeutic linear echoendoscope (GF-UC140P or GF-UCT140; Olympus Medical Systems,
Center Valley, PA). Once the scope was seated in the duodenal
bulb, the bile duct was identified and color flow Doppler was
used to confirm the lack of intervening vessels. Next, the bile
duct was accessed, prior to 2009, using a 19-gauge FNA needle
and then using an access needle (EchoTip Access Needle, Cook
Medical Inc., Bloomington, IN) thereafter. The needle was advanced into the lumen of the extrahepatic bile duct, the stylet
was removed, and bile was aspirated to verify positioning within

the bile duct. Next, contrast was injected and a cholangiogram
was obtained. Following the cholangiogram, a long guidewire
[0.035 inch Jagwire (Boston Scientific Corporation, Natick, MA)
or 0.025 inch angled Visiglide wire (Olympus America, Center
Valley, PA)] was then passed through the access needle into the
bile duct. The guidewire was manually manipulated to advance
through the major papilla and was coiled within the duodenum.
The access needle and echoendoscope were then removed, leaving the wire in place. Alongside the wire, a duodenoscope (TJF
140 – 160; Olympus Medical Systems, Center Valley, PA) was inserted to the level of the papilla. The biliary tree was then deeply
cannulated with a sphinctertome using the guidewire placed via
EUSr as a guide to where the biliary opening lay. If cannulation
was unsuccessful using this technique, then the luminal end of
the guidewire was grasped with a snare or forceps and pulled
through the duodenoscope so that both ends of the guidewire exited the patient’s mouth and were under the control of the
endoscopist. This allowed a sphinctertome or balloon catheter
to be advanced over the wire directly into the biliary tree. Subsequently, a biliary stent was placed across the stricture. Technical
success of EUSr was defined by the wire being advanced into the
duodenum via the major papilla and a stent placed in a retro" Fig. 1). Patients were not routinely admitted to
grade manner (●
the hospital for observation following EUSr if the procedure was
performed on an outpatient basis.
PBD was performed by experts in Interventional Radiology under
moderate sedation using well established techniques [7]. Most
patients initially received external biliary drainage which at the
discretion of the attending radiologist could be converted to a
metallic biliary stent when clinically appropriate [7]. Patients
were monitored in the hospital for a minimum of 23 hours following PBD placement. Following PBD placement, any repeated
procedure (stent/tube exchange) was recorded as repeated interventions.
Procedure-related adverse events (AEs) were divided into early
(within 7 days) and late (greater than 7 days) from the index procedure. AE recorded included recurrent biliary obstruction,
bleeding (defined as an acute > 3 g/dL drop in Hgb requiring
PRBC transfusion or overt bleeding outside of what is typically
accepted post procedure that required further medical/surgical
management) , pancreatitis, bile leak and cholecystitis.

Statistical analysis
Data are reported as mean ± standard deviation (SD) for normally
distributed data, and median and range for skewed data. Grouped
continuous variable data were compared using two-tailed Student’s t test and Mann-Whitney U test where appropriate. Intergroup and categorical comparisons were made using the Chisquare and Fisher’s exact tests. A p value of < 0.05 was required
for statistical significance. All statistical analyses were performed
using PASW 19.1 (SPSS, Inc., Chicago, IL).

Results
!

During the 12-year study period, 1076 patients underwent an initial ERCP for malignant distal biliary obstruction at our medical
center, biliary access via ERCP was unsuccessful in 54 (5.0 %). Four
patients elected to pursue hospice care after failed ERCP, and further attempts at biliary decompression were not made. Fifty patients [mean age 66.5 ±12.6 years, 28 (54.9 %) females] were included in this study. The etiology of MDBO was pancreaticobili-
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Fig. 1 EUS-guided rendezvous in an 84-year-old patient with obstructive jaundice due to an ampullary cancer. a Endoscopic examination revealed a large
mass, which made identification of the biliary orifice impossible. b Endosonographic examination revealed marked biliary ductal dilation and due to direct
extension of the tumor into the bile duct lumen. c Under endosonographic guidance the bile duct was punctured and a cholangiogram was obtained,
confirming findings observed on EUS examination. d,e Next, a guide wire was advanced into the duodenum and via the EUS needle. f Finally a covered metal
biliary stent was placed in a retrograde manner.

ary malignancy in 44 (88 %) and metastatic malignancy in 6 (12 %)
cases. In the EUSr group, pancreaticobiliary malignancies included pancreatic adenocarcinoma in 20 (80 %), neuroendocrine tumor in 1 (4 %), and ampullary/duodenal cancer in 3 (12 %) patients. Patients underwent a median of 1 (range 1 – 3) unsuccessful ERCP attempts. The reason for failed biliary cannulation at
time of ERCP was tumor-related ampullary deformity in 34 (68
%) cases and inability to cannulate a normal appearing ampulla
in 16 (32 %). There were no significant differences in any of the
" Tabaseline characteristics between the EUSr and PBD groups (●
ble 1).
Biliary drainage was technically successful by EUSr in 19 (76 %)
" Table 2). Median
cases and by PBD in 25 (100 %) (P = 0.002, ●
length of hospital stay after initial drainage was 1 day (range 0 –
26) in the EUSr group vs 5 days (range 1 – 20 days) in the PBD
group (P = 0.02). The median length of hospital stay following successful EUSr was 1 day (range 0 – 13), significantly shorter than
the PBD group (P = .002). Nine patients in the EUSr group underwent the procedure on an outpatient basis and were not admitted to the hospital within the subsequent 14 days. Clinical
success, defined as a 50 % drop in bilirubin within 7 days of the
index procedure was obtained in 24 (96 %) in the EUSr group
and 20 (80 %) of those in the PTC grou Five patients in the EUSr
and 5 patients in the PBD group underwent a pancreaticoduodenectomy at a median of 12 days (range 7 – 165) following biliary
drainage; there were no intraoperative of postoperative biliary
complications.

" Table 3.
EUSr was unsuccessful in 6 cases (24 %); summarized in●
Reasons for failed EUSr included inability to pass the guidewire
antegrade into duodenum (n = 5), inability to locate a safe window EUS for biliary puncture due to duodenal deformity (n = 1).
In cases where EUSr was unsuccessful, biliary drainage was obtained by PBD (n = 3), repeat ERCP (n = 2), and EUS-guided choledochoduodenostomy (n = 1). Both patients who had biliary access
obtained through repeat ERCP underwent the procedure within
24 hours after EUSr was attempted. The median time to PBD following failed ERCP was 1 (range 0 – 3) day. The median hospital
length of stay for failed EUSr was 4 days (range 0 – 26), which
was similar to the primary PBD group (5 days, P = 0.64).

Table 1

Baseline demographics.

EUSr

PBD

(n = 25)

(n = 25)

P value

Age (years; mean ± SD)

65.4 ± 11.6

67.7 ± 13.6

0.25

Gender (female)

15

13

0.57
0.12

Etiology of biliary obstruction
Pancreatobiliary malignancy

24

20

Metastatic malignancy

1

5

Unsuccessful ERCP attempts
(median, range)

1 (1 – 3)

1 (1 – 2)

0.26

0.54

Reason for failed ERCP
Tumor invasion/ deformity

18

7

Normal ampulla

16

9
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Table 2

Post-procedure, per protocol analysis.

EUSr (n = 25)

PBD (n = 25)

P value
0.009

Initial technical success

19

25

Clinical success (reduction in bilirubin > 50 %

24/25 (96 %)

20/25 (80 %)

Mean pre-EUS-BD bilirubin

10.85

13.24

Mean post-EUS-BD bilirubin

1.89

3.13

Length of hospital stay following initial drainage (median, range)

1 day (0 – 26)

5 days (1 – 20)

0.022

Follow-up duration after initial drainage (median, range)

37 days (5 – 476)

11 (1 – 272)

0.013

Repeat procedure

3

15

0.001

Number repeat procedures (median, range)

0 (0 – 1)

1 (0 – 10)

0.001

Table 3

Patient

Patients who failed EUSr.

Age

Year of

Endoscopist

Primary

Reason

Method of

Length of

Clinical

Early adverse

Repeat

Study

(1 – 5)

cancer

EUSr failed

biliary decom-

hospital

success

event(s)

biliary

pression

stay

intervention

1

69

2013

1

Pancreatic

Wire did
not pass
into
duodenum

PBD

4 days

Yes

Bleeding from
PBD tract, treated with PBD
replacement

yes

2

72

2013

1

Pancreatic

Could not
access bile
duct by EUS
due to
duodenal
deformity

ERCP

4 days

Yes

None

yes

3

59

2013

1

Ampullary

Wire did
not pass
into
duodenum

EUS-BD

26 days *

yes

None

no

4

75

2009

2

Pancreatic

Wire did
not pass
into
duodenum

PBD

2 days

yes

None

no

5

49

2013

3

Breast

Wire did
not pass
into
duodenum

ERCP

0 days

Yes

None

no

6

47

2014

1

Pancreatic

Wire did
not pass
into
duodenum

PBD

7 days

Yes

None

no

EUSr, endoscopic ultrasound-guided rendezvous

Early AEs occurred in 4 (16 %) patients in the EUSr group and 3
" Table 3). Early AEs included
(12 %) in the PBD groups (P = 0.68, ●
recurrent biliary obstruction (2 PBD), bleeding (2 EUSr, 1 PBD),
pancreatitis (1 EUSr), and bile leak (1 EUSr). In the EUSr group,
bleeding was related to a gastroduodenal artery pseudoaneurysm in 1 patient and was successfully treated with percutaneous
embolization; a second patient developed hemobilia from a PBD
after a failed EUSr, this was successfully treated by re-positioning
of the PBD. In the PBD group one patient developed hemobilia;
this was successfully treated with PBD repositioning and did not
require vascular intervention. Delayed AE occurred in 3 (12 %) patients in the EUSr group and 6 (5 %) in the PBD group (P = 0.27)
" Table 4).
(●
Repeat biliary intervention was required for 3 patients in the
EUSr group and 14 in the PBD group (P = 0.001). Scheduled biliary
interventions, including drain and stent changes were required
in 14 patients in the PBD group, a median of 19 days (range 1 –
33) following initial drainage and in 3 patients in the EUSr group,

a median of 5 days (range 1 – 105) later (P < 0.001). Conversion of
PBD to metal biliary stent was successful in 10 (40 %) patients following initial PBD placement. Recurrent biliary obstruction, requiring intervention occurred in 4 patients in the PBD group, at
a median of 237 days (range 1 – 272) after initial drainage and in
one patient in the EUSr group, 476 days after stent placement
" Fig. 2, Log Rank P = 0.01).
(●

Discussion
!

Since being first reported in 2001 by Giovannini et al., EUS-BD
has been increasingly used as an alternative in patients with
MDBO who fail ERCP [8]. Numerous techniques have been and
are being developed with growing data supporting its use and efficacy [1 – 5, 9 – 14]. In our study, EUSr was found to be a safe and
effective method of biliary drainage in patients with MDBO after
failed initial ERC It was associated with shorter post-procedure
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Table 4

Adverse events.

Adverse events

EUSr

PBD

Early (< 7 days)

4

3

Biliary obstruction

0

2

Bleeding

2

1

Pancreatitis

1

0

Bile leak

1

0

Late (> 7 days)

3

6

Biliary obstruction

2

5

Cholecystitis

1

1

0.68

0.27

EUSr, endoscopic ultrasound-guided rendezvous; PBD, percutaneous biliary drainage

1.0

0.8

Cum Survival

E984

0.6

0.4

Rendezvous

0.2

PTC
Rendezvous-censored
PTC-censored

0.0
0.00

100.00

200.00

300.00

400.00

500.00

Time (days)

Fig. 2

Kaplan Meyer Estimate of time to biliary obstruction.

hospital stay and required fewer follow-up biliary interventions
than PBD.
Three techniques have been developed including EUS-guided
antegrade transluminal drainage (stenting using a transgastric
or transduodenal approach without accessing the papilla), EUSguided antegrade transpapillary stent placement, and EUSr.
From a large analysis of EUS-guided biliary techniques, the overall success rate of EUSr is estimated to be 81 % with a complication rate about 10 % of cases [6]. We recognize that there has
been a more recent push for utilizing a protocol based approach
to different rendezvous techniques, with some endoscopists favoring step wise attempts at biliary access starting with the
trans-intrahepatic approach [15]. However, our standard approach to EUS-guided biliary access during the study period was
EUSr, specifically utilizing the transduodenal approach with the
echoendoscope seated in the duodenal bulb. This decision was
based primarily on the concern for occurrence of bile leak, peritonitis and bleeding associated with creation of a fistula between
the lumen of the gastrointestinal tract and the biliary tree when
the antegrade approach is used or transluminal stenting is performed [6]. While these complications are relatively uncommon,
there consequences can be devastating; particularly in the 20 % of
patients with potentially resectable pancreaticobiliary tumors.

With the recent introduction of lumen opposing stents, EUSguided choledochoduodenosotmy has become an attractive alternative to EUS-guided biliary decompression.[16] However,
the currently available lumen opposing stents were not designed
specifically for the biliary tree and may pose a risk of cholecystitis
in patients with a gallbladder in situ as well as stent erosion or
migration. Thus, we feel that if EUS guided biliary drainage is attempted rendezvous should remain the preferred first line approach, given the fact that it preserves the anatomic integrity of
the biliary tree and avoid creation of a fistula.
It remains unclear whether EUS techniques are superior in efficacy, safety, and cost when compared to PBD in patients with
MDBO who have failed ERC It is well known that PBD is highly
successful but generally requires repeat procedures and periprocedural adverse events are not infrequent rates ranging from 10 %
to 32 % in the modern literature [6]. In a recent study, Khashab et
al studied a group of 73 patients with MDBO who failed repeat
ERCP and found that technical success was higher in the PBD
group but the adverse event rate was higher in the latter group
of patients. Regarding successful biliary drainage, defined as reduction in total bilirubin by 50 % in 2 weeks, the groups were
not statistically different [2]. However, a major critique of the
study is patients were enrolled to the PBD group only after failed
ERCP and EUS-BD; potentially biasing the study against PBD.
In our study AE rates were similar between the EUSr and PBD
groups. However, recurrent biliary obstruction occurred more
frequently and repeated procedures were required more often
in the PBD grou Repeated biliary manipulation may lead to further complications and requires the patient to have repeated hospital visits for catheter checks and changes. Recurrent biliary obstruction is a major source of morbidity and treatment interruption in patients undergoing chemotherapy. Given the fact that
EUSr is associated with a lower rate of recurrent biliary obstruction it stands to reason that this approach would be preferable in
patients receiving neoadjunct or palliative chemotherapy [17,
18]. Moreover, the length of hospital stay was significantly shorter in the EUSr group, landing another advantage to EUSr; particularly in cases where the initial ERCP is performed on an outpatient basis and if EUSr is performed in the same endoscopic
session. Finally, we hypothesize that patients would experience
a lower quality of life following PBD when compared to EUSr as
external drainage catheters typically repeated interventions.
It cannot be understated however, that there are important advantages of PBD. First, PBD is more widely available and the techniques of PBD are well established and standardized. Furthermore, complications of PBD are typically minor and do not require surgical backup that may only be available at tertiary medical centers. That being said, EUS techniques have a key advantage
of being performed at the same session of ERC However, if initial
EUSr fails, it could be argued that PBD is a safer therapeutic option given no need for repeat anesthesia and its almost universal
technical success. Technology, ie stents and guidewires, that focus solely on EUS-BD are needed and currently in development
[19, 20]. With the development of technology and as experience
by interventional endoscopists is gained, the technical success
rates of EUS-BD are likely to improve.
The major limitation of our study is its retrospective nature and
limitations inherent to this design. The use of historical controls
may have introduced some degree of bias; however there were
no significant differences in the baseline characteristics and the
protocol (minimum of 23 hours inpatient observation) following
PBD placement remains the same at our institution. We also de-
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tected no difference in the rate of adverse events comparing EUSr
and PBD, however our sample size may be insufficient to detect a
meaningful difference in this regard. Additionally, this was a single-center study; results may not be applicable to institutions
with different practice patterns for endoscopic and percutaneous
biliary drainage. Finally, we focused our study on patients with
malignant distal biliary obstruction and we cannot comment on
the efficacy and safety of EUS guided biliary drainage in the treatment of hilar biliary structures or benign biliary disease.

Conclusions
!

In summary, EUSr is a safe and effective method of biliary drainage in patients with MDBO after failed ERC Initial technical success with EUSr was significantly lower than with PBD, however
when EUSr was successful patients had a significantly shorter
post-procedure hospital stay and required fewer follow-up biliary interventions than those undergoing PBD.
Competing interests: None
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